全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

戈米辛N治疗自身免疫性肝炎的机制研究
Research on the Mechanism of Gomisun N in the Treatment of Autoimmune Hepatitis

DOI: 10.12677/md.2025.153043, PP. 319-328

Keywords: 自身免疫性肝炎,戈米辛N,炎症因子,刀豆蛋白A
Autoimmune Hepatitis
, Gomisun N, Inflammatory Factors, Concanavalin A

Full-Text   Cite this paper   Add to My Lib

Abstract:

自身免疫性肝炎是一种以肝脏炎症为特征的慢性疾病,主要由机体免疫系统错误地攻击自身肝细胞引起。该疾病的发病率在不同人群中有所差异,尤其在女性中更为常见,且其临床表现多样,包括乏力、黄疸、腹痛等,严重时可导致肝衰竭。尽管目前已有多种治疗方法,如免疫抑制剂和肝移植,但仍存在疗效不佳和副作用等问题。因此,寻找新的治疗策略显得尤为重要。戈米辛N是一种从植物中提取的生物活性成分,近年来的研究表明其具有显著的抗炎作用,能够通过调节免疫反应来减轻炎症。因此,本研究旨在探讨戈米辛N预给药对刀豆蛋白诱导的小鼠自身免疫性肝炎模型中炎症反应的影响。
Autoimmune hepatitis is a chronic disease characterized by inflammation of the liver, primarily caused by the immune system mistakenly attacking its own liver cells. The incidence of this disease varies among different populations, being more common in women, and its clinical manifestations are diverse, including fatigue, jaundice, and abdominal pain, which can lead to liver failure in severe cases. Although there are various treatment methods available, such as immunosuppressants and liver transplantation, issues like poor efficacy and side effects still exist. Therefore, finding new treatment strategies is particularly important. Gomisinin N is a bioactive component extracted from plants, and recent studies have shown that it has significant anti-inflammatory effects, capable of alleviating inflammation by regulating immune responses. Thus, this study aims to explore the effects of Gomisinin N pre-treatment on the inflammatory response in a mouse model of autoimmune hepatitis induced by concanavalin A.

References

[1]  Czaja, A.J. (2017) Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis. Digestive Diseases and Sciences, 62, 2277-2292.
https://doi.org/10.1007/s10620-017-4675-y
[2]  Boberg, K.M. (2002) Prevalence and Epidemiology of Autoimmune Hepatitis. Clinical Liver Disease, 6, 635-647.
https://pubmed.ncbi.nlm.nih.gov/12362572/
[3]  Muri Boberg, K. (2002) Prevalence and Epidemiology of Autoimmune Hepatitis. Clinics in Liver Disease, 6, 635-647.
https://doi.org/10.1016/s1089-3261(02)00021-1
[4]  Feld, J. and Heathcote, E. (2003) Epidemiology of Autoimmune Liver Disease. Journal of Gastroenterology and Hepatology, 18, 1118-1128.
https://doi.org/10.1046/j.1440-1746.2003.03165.x
[5]  Taylor, S.A., Assis, D.N. and Mack, C.L. (2019) The Contribution of B Cells in Autoimmune Liver Diseases. Seminars in Liver Disease, 39, 422-431.
https://doi.org/10.1055/s-0039-1688751
[6]  Chen, H., Han, Z., Fan, Y., Chen, L., Peng, F., Cheng, X., et al. (2023) CD4+ T-Cell Subsets in Autoimmune Hepatitis: A Review. Hepatology Communications, 7, e0269.
https://doi.org/10.1097/hc9.0000000000000269
[7]  Montes Santiago, J., Gambón Deza, F., García García, M.J., González Vázquez, L., Hermo Brión, J.A. and Pérez Alvarez, R. (2000) Usefulness of Autoantibodies in the Study of Autoimmune Liver Diseases and Prevalence of Autoimmune Extrahepatic Manifestations. Annals of Internal Medicine, 17, 343-346.
[8]  Tu, H., Chen, D., Cai, C., Du, Q., Lin, H., Pan, T., et al. (2019) microRNA‐143‐3p Attenuated Development of Hepatic Fibrosis in Autoimmune Hepatitis through Regulation of TAK1 Phosphorylation. Journal of Cellular and Molecular Medicine, 24, 1256-1267.
https://doi.org/10.1111/jcmm.14750
[9]  Pronicki, M. (2017) Wilson Disease—Liver Pathology. In: Handbook of Clinical Neurology, Elsevier, 71-75.
https://doi.org/10.1016/b978-0-444-63625-6.00007-0
[10]  Koay, L.B., Tsai, S.L., Sun, C.S. and Wu, K.T. (2008) Chronic Autoimmune Hepatitis with Epstein-Barr Virus Superinfection: A Case Report and Review of Literature. Hepatogastroenterology, 55, 1781-1784.
[11]  Seki, E. and Schwabe, R.F. (2015) Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways. Hepatology, 61, 1066-1079.
https://doi.org/10.1002/hep.27332
[12]  Henze, L., Schwinge, D. and Schramm, C. (2020) The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases? Frontiers in Immunology, 11, Article No. 1567.
https://doi.org/10.3389/fimmu.2020.01567
[13]  Roma, M., Bonetto, S., Giovo, I., Campion, D., Rizzi, F., Peroni, C.L., et al. (2024) Liver Involvement in Adult-Onset Still’s Disease: Our Experience in a Third Level Liver Unit and Review of the Literature. Minerva Gastroenterology, 69, 537-545.
https://doi.org/10.23736/s2724-5985.21.02897-7
[14]  Kemme, S. and Mack, C.L. (2021) Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis. Pediatric Clinics of North America, 68, 1293-1307.
https://doi.org/10.1016/j.pcl.2021.07.006
[15]  Han, S., Tredger, M., Gregorio, G.V., Mieli-Vergani, G. and Vergani, D. (1995) Anti-Liver Cytosolic Antigen Type 1 (LC1) Antibodies in Childhood Autoimmune Liver Disease. Hepatology, 21, 58-62.
https://doi.org/10.1002/hep.1840210111
[16]  Wang, X., Wang, P. and Yang, X. (2018) Research Progress on Systemic Lupus Erythematosus Overlapping Organ-specific Autoimmune Diseases. Journal of Zhejiang University. Medical Sciences, 47, 435-440.
[17]  Enweluzo, C., Aziz, F. and Mori, A. (2013) Comparing Efficacy between Regimens in the Initial Treatment of Autoimmune Hepatitis. Journal of Clinical Medicine Research, 5, 281-285.
https://doi.org/10.4021/jocmr1486w
[18]  Porta, G., Carvalho, E.d., Santos, J.L., Gama, J., Borges, C.V., Seixas, R.B.P.M., et al. (2019) Autoimmune Hepatitis in 828 Brazilian Children and Adolescents: Clinical and Laboratory Findings, Histological Profile, Treatments, and Outcomes. Jornal de Pediatria, 95, 419-427.
https://doi.org/10.1016/j.jped.2018.04.007
[19]  Wang, W., Guo, H., Li, H., Yan, Y., Wu, C., Wang, X., et al. (2018) Interleukin-35 Gene-Modified Mesenchymal Stem Cells Protect Concanavalin A-Induced Fulminant Hepatitis by Decreasing the Interferon Gamma Level. Human Gene Therapy, 29, 234-241.
https://doi.org/10.1089/hum.2017.171
[20]  Wei, X., Cheng, X., Luo, Y. and Li, X. (2023) Umbilical Cord-Derived Mesenchymal Stem Cells Attenuate S100-Induced Autoimmune Hepatitis via Modulating Th1 and Th17 Cell Responses in Mice. Stem Cells International, 2023, Article ID: 9992207.
https://doi.org/10.1155/2023/9992207
[21]  Araki, R., Hiraki, Y., Nishida, S., Inatomi, Y. and Yabe, T. (2016) Gomisin N Ameliorates Lipopolysaccharide-Induced Depressive-Like Behaviors by Attenuating Inflammation in the Hypothalamic Paraventricular Nucleus and Central Nucleus of the Amygdala in Mice. Journal of Pharmacological Sciences, 132, 138-144.
https://doi.org/10.1016/j.jphs.2016.09.004
[22]  Bak, J., Lee, S.J., Kim, T.W., Hwang, S., Park, M.J., Arunachalam, R., et al. (2023) Schisandrol a and Gomisin N from Schisandra chinensis Extract Improve Hypogonadism via Anti-Oxidative Stress in TM3 Leydig Cells. Nutrition Research and Practice, 17, 1-12.
https://doi.org/10.4162/nrp.2023.17.1.1
[23]  Hosokawa, Y., Hosokawa, I., Shindo, S., Ozaki, K. and Matsuo, T. (2016) Gomisin N Decreases Inflammatory Cytokine Production in Human Periodontal Ligament Cells. Inflammation, 40, 360-365.
https://doi.org/10.1007/s10753-016-0482-4
[24]  Nagappan, A., Jung, D.Y., Kim, J., Lee, H. and Jung, M.H. (2018) Gomisin N Alleviates Ethanol-Induced Liver Injury through Ameliorating Lipid Metabolism and Oxidative Stress. International Journal of Molecular Sciences, 19, Article No. 2601.
https://doi.org/10.3390/ijms19092601
[25]  Jang, M.-K., Yun, Y.-R., Kim, J.-H., et al. (2016) Gomisin N Inhibits Adipogenesis and Prevents High-Fat Diet-Induced Obesity. Scientific Reports, 7, Article No. 40345.
[26]  Yun, Y., Kim, J., Kim, J.H. and Jung, M.H. (2017) Protective Effects of Gomisin N against Hepatic Steatosis through AMPK Activation. Biochemical and Biophysical Research Communications, 482, 1095-1101.
https://doi.org/10.1016/j.bbrc.2016.11.164
[27]  Liu, F., Li, S., Gu, Y., Chen, P., Yao, R., Wang, S., et al. (2025) Comprehensive Two-Dimensional Primary Hepatic Stellate Cell (HSC) Membrane Chromatography-Based Screening of Anti-Fibrotic Components from Schisandra Chinensis (turcz.) Baill. and Mechanistic Insights into Gomisin N against Liver Fibrosis. Journal of Ethnopharmacology, 351, Article 120067.
https://doi.org/10.1016/j.jep.2025.120067
[28]  Lee, K., Lee, Y.-J., Kim, K.-J., et al. (2020) Gomisin N from Schisandra chinensis Ameliorates Lipid Accumulation and Induces a Brown Fat-Like Phenotype through AMP-Activated Protein Kinase in 3T3-L1 Adipocytes. International Journal of Molecular Sciences, 21, 2153.
[29]  Zhu, P., Lam, D.F., Li, J., Fu, X., Yin, C., Chou, J., et al. (2020) Gomisin N Exerts Anti-Liver Cancer Effects and Regulates PI3K-Akt and mTOR-ULK1 Pathways in Vitro. Biological and Pharmaceutical Bulletin, 43, 1267-1271.
https://doi.org/10.1248/bpb.b20-00030
[30]  王子文, 刘兆玉. 戈米辛G抑制HepG2细胞生长的机制研究[J]. 中国临床药理学杂志, 2022, 38(8): 768-771.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133